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Abstract
Background: Hypertension is a public health problem with mostly unknown causes, and where strong hereditary
genetic alterations have not been fully elucidated. However, the use of experimental models has provided valuable
information. Recent evidences suggest that alterations in key nephrogenic factors, such as Wilms’ tumor 1 transcription
factor (WT-1), could contribute to the development of hypertension. The aim of this paper is to evaluate the expression
of WT-1 and related genes in the nephrogenic process in connection with the development of hypertension as well as
the corresponding anatomical and functional correlation.
Methods: Male spontaneously hypertensive and control rats were evaluated weekly from birth until week 8 of life.
Their blood pressure was taken weekly using the tail-cuff blood pressure system. Weekly, 5 rats per group were
sacrificed with a lethal injection of pentobarbital, and their kidneys were removed, decapsulated and weighed. The
serum was collected for measuring biochemical parameters. The results were assessed using one-way analysis of
variance for comparisons between groups.
Results: The relationship between renal weight/total body weights was established, without significantly different
values. These data were compared with apoptosis, fibrosis, number and size of the glomeruli. The elevation of systolic
blood pressure was significant since week 6. Biochemical values differed slightly. Histology showed a slight increase in
deposits of collagen fibers since week 4. Additionally, in kidney cortices, the expression of WT-1, heat shock protein 70
(Hsp70) and vitamin D receptors (VDR) decreased since week 4. Finally, we demonstrated ultrastructural damage to
mitochondria since week 4.
Conclusions: Our results would suggest an unprecedented link, possibly a regulatory mechanism, between WT-1 on
nephrogenic alteration processes and their relationship with hypertension. Moreover, and previous to the increase in
blood pressure, we demonstrated low expressions of WT-1, VDR and Hsp70 in kidneys from neonatal SHRs. If so, this
may suggest that deregulation in the expression of WT-1 and its impact on nephrogenesis induction could be crucial
in understanding the development and maintenance of hypertension.
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Background
Hypertension is one of the most complex diseases to
understand due to its strong genetic component.
Although the genetic basis of the disease is firmly estab-
lished and there have been very important developments
in the field of molecular biology in recent years, few
studies deal with hypertension as a result of possible
changes in renal development by decoupling organo-
genic key factors [1]. In this regard, nephrogenic impair-
ment is often associated with low birth weight and has
been recognized as a powerful risk factor for kidney dis-
ease with low glomerular filtration rate, which would
condition a more rapid progression of kidney disease
and hypertension [2]. Of special interest is the fact that
one important consequence of the altered nephrogenic
process is hypertension. Kidney damage is a significant
event in the development of hypertension and, thus, ma-
ternal food restriction alters key fetal nephrogenesis
gene expression, such as Wilms’ tumor transcription fac-
tor 1 (WT-1) and other factors; this appears to contrib-
ute to hypertension development [3, 4]. In addition,
some genes involved in hypertension development also
depend on WT-1. The fact that renin gene transcription
is regulated by WT-1, and that inherited mutations in
the WT-1 gene can lead to hypertension, may explain
the findings of patients with high renin and hypertension
[5]. Accordingly, unpublished results from our labora-
tory assays performed in adult spontaneously hyperten-
sive rats (SHRs) suggested an opposite relationship
between WT-1 renal expression and blood pressure
values. Furthermore, recent hypertension studies show
low levels of vitamin D associated with the exaltation of
the renin-angiotensin-aldosterone system (RAAS) [6–8];
and, in that respect, our laboratory has demonstrated, in
the primary culture of proximal tubular cells of SHRs,
that heat shock protein 70 (Hsp70) protects against
hypertension induced by angiotensin II by exerting a
cytoprotective effect [9]. We have also demonstrated in
adult SHRs that the induction of vitamin D receptor
(VDR) modulates an increase in Hsp70 levels, with a
decrease in the angiotensin II receptor, type 1 (AT1) ex-
pression, providing renal protection [10]. These contri-
butions are relevant considering previous reports, where
WT-1 and Hsp70 are physically associated (localized) in
embryonic rat kidney cells, in primary Wilms’ tumor
samples, and in cultured cells with inducible WT-1 ex-
pression [11]. It has also been described that Hsp70 is
an important cofactor for the function of WT-1, and
suggested a potential role for this chaperone during
nephrogenesis. Furthermore, it has been reported that
human VDR is regulated by WT-1 [12]. These findings
strengthen our recent demonstrations in the adult SHR
model. Here we established, in mitochondria, a signifi-
cant and consistent anatomical-functional correlate with
the expression of the markers/modulators mentioned
above (AT1, VDR and Hsp70) [10]. Moreover, cumula-
tive evidence suggests that reactive oxidative stress
(ROS) and inflammation, with particular attention to
mitochondria, plays an important role in hypertension
development [13, 14]. In this regard, our laboratory
reviewed and proposed a complex new regulation in the
inflammatory pathway that involves the possible modu-
lation of Hsp70 and WT-1 on mitochondrial signaling
and where the net effect would favor cell survival by
WT-1 stabilizing Bcl2, and would limit the potential for
the release of cytochrome C from mitochondria [15].
Finally, SHRs were originally inbred from Wistar rats
and their Wistar–Kyoto (WKY) inbred non-hypertensive
controls. These rats develop hypertension at about
6 weeks of age without physiological, pharmacological or
surgical intervention; however, environmental factors
affect the development of hypertension, and the import-
ance of this model has been attributed to the similarity
of its pathophysiology with essential hypertension in
humans [16].
Based on the arguments stated above, we finally pro-
posed to evaluate the following key hypothesis: Changes
in the expression pattern of the WT-1 transcription fac-
tor and molecular mediators related to nephrogenesis
could contribute to anatomical and functional kidney
disorders, as well as to a hemodynamics disorders typical
of the SHR model. Such modifications could respond to
a Hsp70-dependent conditioning, as well as a probable
modulation of the vitamin D receptor. In addition, we
discuss the possibility that mitochondrial injury and dys-
function linked to master nephrogenic factors, such as
WT-1, could play a central role in the pathogenesis of
the essential hypertension model.
Methods
Both the SHR group and the control group, formed by
Wistar Kyoto rats (WKY), were cared in accordance
with the Guiding Principles in the Care and Use of Ani-
mals of the United States National Institute of Health.
All experimental procedures were previously approved
by the Institutional Animal Care and Use Committee of
the Medical Sciences College, National University of
Cuyo (Protocol approval N° 46/2015).
Animals
Newborn male SHRs (n = 45) and WKYs (n = 45), were
evaluated during their first 8 weeks of life (from birth,
i.e. week 0, to week 8). Their blood pressure was taken
weekly using the CODA tail-cuff blood pressure system
(Kent Scientific Corporation). Weekly, 5 rats per group
(SHR and WKY), were sacrificed with a lethal injection
of pentobarbital, and their kidneys were removed,
decapsulated and weighed. The serum was collected
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for measuring biochemical parameters. The serum urea
and creatinine concentrations were determined using col-
orimetric assays (Sigma kits).
Histological studies
Sections of the renal cortex were processed for histo-
logical studies according to previously described [17].
Morphometric evaluation of interstitial fibrosis
For all morphologic evaluations, the observer was
blinded to the origin of the histological sections. A
standard point counting method was used to quantitate
the fibrosis of the renal interstitium [18–20]. Results
were expressed as percentage of measured area.
Glomerular morphometric analysis
Masson’s trichrome stained sagittal sections of the rat
kidney cortices were scanned under light microscopy
with a zig-zag movement so as to assure equal sampling
of the cortex and to avoid evaluating the same glomeru-
lus twice. The morphometric parameters were evaluated
as previously [19], with minor modifications. The rela-
tive number of glomeruli per square millimeter of renal
cortex was calculated. A reticulate eyepiece was used for
counting glomeruli. To avoid double counting, glomeruli
crossed by the upper and left margins of the reticle were
counted in 10 fields of tissue section. The number of
glomeruli per microscopic field was counted in every
section observed (100 fields). To assess the relative
glomerular diameter, a micrometric eyepiece was
used. Ten tissue sections per microscopic field were
taken at random. The diameters were expressed in
micrometers (μm).
Identification of cellular apoptosis: the TUNEL technique
Cellular apoptosis by terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling technique
was performed according to previously reported [20].
Electron microscopy
The tissue samples were processed for electron micros-
copy according to previously described methodology
with minor modifications [20].
Immunohistochemical studies
Kidney paraffin sections were processed according to
previously described technique with minor modifications
[21]. The antibodies applied were rabbit polyclonal anti-
body against WT-1 (C-19), mouse monoclonal antibody
against VDR (D-6), rabbit polyclonal antibody against
Hsp70 (H-300) and rabbit polyclonal antibody against
AT1 (306) (Santa Cruz Biotechnology, Inc.), diluted at
1:500. A commercial immunoperoxidase kit was used
(Dako). The positive reaction was evaluated considering
the specific location of the immunostaining and the
intensity of the immunoreaction. The negative controls
included tissues unexposed to primary antibodies as well
as tissues exposed to control immunoglobulin G. The
positive controls were human breast cancer biopsy sam-
ples. The immunostaining was evaluated and resolved by
consensus according to a scoring system reported previ-
ously [22, 23].
Immunofluorescence confocal microscopy
The kidneys were processed according to previously
described technique [21]. Primary antibodies were: poly-
clonal anti-WT-1 (1:100) (Santa Cruz Biotechnology),
monoclonal anti-Hsp70 (1:100) (Sigma Aldrich), mono-
clonal anti-VDR (1:100) (Santa Cruz Biotechnology), and
polyclonal anti-AT1 (1:100) (Santa Cruz Biotechnology).
Secondary antibodies were: goat anti-rabbit IgG anti-
body, Cy2 conjugated (1:750) and donkey anti-mouse
IgG antibody, Cy3 conjugated (1:750). After being
washed, the tissues were stained with Hoechst 33342 (10
nM) for 5 min. The coverslips were mounted in Fluor-
oshield solution (Sigma Aldrich) for confocal micros-
copy. Confocal images were taken using FV10-ASW 1.7
(Olympus IX81 microscope).
Mitochondria isolation from tissue
Mitochondria isolation and purity of mitochondrial frac-
tions were established as previously described [24, 25]
with minor modifications.
NADPH activity assay
NADPH oxidase activity was measured in enriched
mitochondrial fractions of the renal cortex using the
Luminol (5-amino-2, 3-dihydro-1, 4-phthalazine; Sigma-
Aldrich) technique. The values were expressed as rela-
tive fluorescence units (RFU) per microgram of protein
and per minute of incubation.
Statistical analysis
The results were assessed using one-way analysis of vari-
ance (ANOVA) for comparisons between groups. Differ-
ences between groups were determined using the
Bonferroni posttest. A p < 0.05 was considered to be
significant. Results are given as mean ± standard error of
the mean (SEM). Statistical tests were performed using
GraphPad InStat version 3.00 for Windows 95 (Graph-
Pad Software, Inc., La Jolla, California, United States of
the America).
Results
Weight, hemodynamics and serum chemistry
The body weights in each strain increased rapidly from
newborn to 8 weeks of life. However, the differences in
body weights between the two strains were enlarged
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after week 6, and by week 8 the SHRs and WKYs
weighed 160 ± 10 g and 190 ± 12 g (p < 0.05), respectively
(n = 5 per week/per group). We also evaluated the renal
weight/total body weight ratio, and found no significant
differences between the strains (SHR vs. WKY; p =NS)
in the weeks studied (n = 5 per week/per group). On the
other hand, due to the low weight of the animals, we
could only measure the systolic blood pressure (SBP) ac-
curately since week 4 of life until the end of the study
(week 8). The SBP in both strains, SHR and WKY, was
195 ± 10 vs. 145 ± 8 mmHg; p < 0.05 at week 6. There-
after, the blood pressure of the SHRs elevated to
250 mmHg at week 8. In contrast, the SBP of the
WKYs was 145 ± 8 and 150 ± 10 mmHg at weeks 6
and 8 (p = NS) (n = 5 per week/per group) (Table 1).
The study of biochemical parameters (n = 5 per week/
per group) showed an increasing tendency for both
serum urea and creatinine of hypertensive rats (SHR)
and their normotensive controls (WKY). However, since
week 4, creatinine values in SHRs were slightly lower
than in WKYs (0.65 ± 0.03 vs. 0.75 ± 0.04 mg/dl; p =NS).
In contrast, the values of plasma urea in SHRs were dis-
creetly higher than in WKYs (15 ± 2 vs. 13 ± 1.6 mg/dl;
p = NS). Relevant to our study was that, at week 8, cre-
atinine values in SHRs were lower than in WKYs (0.70 ±
0.06 vs. 0.95 ± 0.07 mg/dl; p < 0.05), while the values of
plasma urea in SHRs were higher than in WKYs (20 ± 2
vs. 15 ± 2 mg/dl; p < 0.05) (Table 2).
Interstitial fibrosis, apoptosis, and ultrastructural
mitochondrial damage during hypertension development
Figure 1a shows, from week 4 of life, the degree of tubu-
lointerstitial fibrosis in the renal cortices of SHR kidneys.
Compared to those, WKY kidneys showed a lower colla-
gen accumulation in the expanded interstitium along
with cellular interstitial infiltrates in the cortex. In
addition, SHR kidneys at week 8 had more significant
interstitial collagen deposition compared to what was
seen in WKY kidneys. The interstitial fibrotic area in
SHRs revealed a twofold expansion of the interstitial
space compared to WKYs (50 ± 8 vs. 25 ± 10 %; p < 0.05,
n = 5) (Fig. 1a).
Figure 2a shows, from week 4 of life, an increased
number of TUNEL-positive apoptotic cells in tubular
epithelial cells from SHRs compared to those from
WKYs. Interestingly, the number of TUNEL-positive
apoptotic cells in 8-week-old SHRs was significantly
higher than the number found in WKYs (30 ± 4 vs. 18 ±
4; p < 0.05, n = 5) (Fig. 2a).
Figure 3 shows the results of the electron microscopy
study. In 4-week-old SHRs, the proximal convoluted tu-
bules display normal tubular cells with baseline projec-
tions within normal parameters. They had abundant
mitochondria, mostly with normal ultrastructure, except
that some begin to show changes, such as wider spaces
than expected between the mitochondrial cristae (lumi-
nescent spaces larger than usual, arrow). Conversely, in
4-week-old WKYs, the space between cristae was
normal. On the other hand, the architecture of the renal
tissue obtained from 8-week-old SHRs was composed of
disorganized cortical tubules, and the cellular structure
was also altered. These cells contained vacuoles of differ-
ent sizes, mitochondria with cristae (arrow in SHR)
separated by widened spaces between them –some of
them containing vacuoles and dense bodies surrounded
by membranes. In 8-week-old WKYs, the cytoplasm and
Table 1 Body weight, kidney/body weight ratio, and blood pressure in SHRs and WKYs
Strain 0-week-old
rat
1-week-old
rat
2-week-old
rat
3-week-old
rat
4-week-old
rat
5-week-old
rat
6-week-old
rat
7-week-old
rat
8-week-old
rat
SHR
Body weight (g) 6 ± 1 13 ± 3 24 ± 4 45 ± 6 82 ± 7 100 ± 10 130 ± 9* 150 ± 9* 160 ± 10*
WKY
Body weight (g) 7 ± 1 17 ± 4 29 ± 5 54 ± 7 92 ± 8 115 ± 9 150 ± 8 175 ± 10 190 ± 12
SHR
Renal/Body weight
(mg/g)
5.60 ± 0.3 6.05 ± 0.90 5.9 ± 1.00 5.86 ± 0.90 6.02 ± 1.10 7 ± 1.30 7.7 ± 1.00 7.5 ± 1.20 8 ± 1.20
WKY
Renal/Body weight
(mg/g)
6.1 ± 0.30 7.43 ± 1.10 6.66 ± 1.10 6.9 ± 1.20 6.82 ± 1.20 6.3 ± 1.20 7.3 ± 1.10 6.7 ± 1.10 7.3 ± 1.10
SHR
SBP (mmHg) ————— ————— ————— ————— 142 ± 11 150 ± 10 195 ± 10** 230 ± 15** 250 ± 20**
WKY
SBP (mmHg) ————— ————— ————— ————— 135 ± 8 140 ± 7 145 ± 8 148 ± 7 150 ± 10
Significantly different from the values at 6, 7 and 8 weeks of age in each strain (*p < 0.05 and **p < 0.01). Results are mean ± SEM; n = 5
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mitochondria showed a normal appearance for this type
of cell and, in addition, the cortical area of the renal tis-
sue was well-preserved.
Effects of hypertension development on glomerular
morphometry
Figure 4 shows the evaluation of glomerular morphom-
etry. A slight decrease in the number of glomeruli was
found in 4-week-old SHRs in relation to WKYs (10 ± 1.5
vs. 13.5 ± 1.5; p =NS). Similarly, a slight decrease in the
relative glomerular diameter was found in 4-week-
old SHRs in relation to WKYs (90 ± 6 vs. 101 ± 4 μm;
p = NS). However, at week 8, a significant decrease
in the number of glomeruli was found in SHRs with
respect to WKYs (8 ± 1.3 vs. 14 ± 2; p < 0.05. Like-
wise, a significant decrease in the relative glomerular
diameter was found in SHRs with respect to WKYs
(95 ± 6 vs. 130 ± 10 μm; p < 0.05).
Expression of WT-1, VDR, Hsp70 and AT1, and NADPH
activity during hypertension development
Immunocytochemical and immunofluorescence analyses
were performed to establish protein location and immu-
noreaction intensity. Figures 5 and 6 show the expres-
sions of WT-1, VDR, Hsp70 and AT1 in the cortices of
SHRs and WKYs. In the renal cortices of 4-week-old
SHRs, low WT-1, VDR and Hsp70 immunostaining/im-
munofluorescence (Figs. 5a and 6a) was observed in the
epithelial cell cytoplasm. Contrary to this, AT1 staining
was shown in the same epithelial cells from SHRs
(Figs. 5a and 6a). These values were very significant at
week 8 of the study, when a very low WT-1, VDR and
Hsp70 immunostaining/immunofluorescence (Figs. 5a
and 6a) was observed in the epithelial cell cytoplasm.
Conversely, a very high AT1 staining was shown in the
same epithelial cells from SHRs (Figs. 5a and 6a). On the
other hand, in all renal cortices (4, 6 and 8-week-old) of
WKYs, high WT-1, VDR and Hsp70 immunostaining/
immunofluorescence (Figs. 5b and 6b) was observed in
the epithelial cell cytoplasm. Contrary to this, AT1 low
staining was shown in the same epithelial cells from
WKYs (Figs. 5b and 6b). These values were not signifi-
cant. Conversely, a very low AT1 staining was shown in
the same epithelial cells from SHRs (Figs. 5b and 6b).
Furthermore, preliminary results in SHRs by western
blotting and RT-PCR (n = 3) support these results
(Additional files 1: Data S1 and 2: Data S2). Parallel to
this study, Fig. 7 shows, in mitochondrial fractions from
cortices at week 4, that NADPH oxidase activity was sig-
nificantly greater in SHRs than in WKYs (13,000 ± 500
vs. 11,500 ± 500 RFU/μg prot/min; p < 0.05, n = 5). Inter-
estingly, the NADPH oxidase activity in 8-week-old
SHRs was significantly higher than the activity found in
the WKY group (17,000 ± 600 vs. 13,500 ± 700 RFU/μg
prot/min; p < 0.01, n = 5). In consequence, the NADPH
oxidase activity gradually grew throughout the study.
Discussion
This paper is the first report showing that, in the natural
history of hypertension, ultrastructural mitochondrial
damage occurs first, before hemodynamic clinical mani-
festations appear. Therefore, altered mitochondrial en-
ergy metabolism linked to master nephrogenic factors,
such as WT-1, could play a central role in the essential
hypertension model, and should be further investigated.
The present study shows WT-1 expression in the late
nephrogenic process associated with hypertension devel-
opment as well as the corresponding anatomical and
functional correlation. Also for the first time, previous to
the increase in blood pressure, we demonstrated low
Table 2 Biochemical parameters in SHRs and WKYs
Strain 0-week-old
rat
1-week-old
rat
2-week-old
rat
3-week-old
rat
4-week-old
rat
5-week-old
rat
6-week-old
rat
7-week-old
rat
8-week-old
rat
SHR
Creatinine
(mg/dl) 0.49 ± 0.08 0.51 ± 0.07 0.55 ± 0.06 0.60 ± 0.05 0.65 ± 0.03 0.67 ± 0.09 0.68 ± 1.00 0.70 ± 0.09 0.70 ± 0.06*
WKY
Creatinine
(mg/dl) 0.55 ± 0.07 0.60 ± 0.08 0.65 ± 0.06 0.70 ± 0.07 0.75 ± 0.04 0.79 ± 0.09 0.85 ± 0.09 0.90 ± 1.10 0.95 ± 0.07
SHR
Urea
(mg/dl) 12 ± 1.00 13 ± 1.00 14 ± 2.00 15 ± 2.00 15 ± 2.00 16 ± 2.00 18 ± 3.00 20 ± 3.00 20 ± 2.00*
WKY
Urea
(mg/dl) 11 ± 1.00 12 ± 2.00 12 ± 2.00 13 ± 2.00 13 ± 1.60 14 ± 2.00 14 ± 2.00 15 ± 4.00 15 ± 2.00
Significantly different from the values at 8 weeks of age in each strain (*p < 0.05). Results are mean ± SEM; n = 5
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expressions of WT-1, VDR and Hsp70 in kidneys from
neonatal SHRs.
As widely known, hypertension is considered one of
the most important public health problems in developed
countries, affecting about one billion people worldwide
(9.4 million deaths/year; World Health Organization
2013). Hypertension occurs as an asymptomatic disease,
although, paradoxically, many changes that precede the
elevation of blood pressure produce specific organic le-
sions, some clinically defined. In addition, the multitude
of contributing factors (environment, sodium intake,
renin, insulin resistance, sleep apnea and age, among
others) makes hypertension complex to study mainly due
to the genetic component associated with its appearance.
Of particular interest to this study is the relationship be-
tween hypertension and kidney disease, which yet remains
unclear and is a matter of considerable research interest,
with evidence suggesting that hypertension is both a cause
and a consequence of kidney disease.
The kidney is an extremely complex structure, consist-
ing of functional units having about 10,000 cells divided
into at least 14 different cell types. This implies that the
renal morphogenesis must be perfectly orchestrated, and
that the conversion of mesenchymal mesodermal cells
into polarized epithelial cells [26] is a critical step of this
process. There is evidence that WT-1 may be directly in-
volved in the regulation of cell proliferation and differen-
tiation. In situ hybridization studies have shown WT-1
to be selectively expressed in the metanephric blastema
and glomerular epithelium during embryonic and fetal
development [27]. The expression patterns of WT-1 in-
dicate an important role of this gene not only during
Fig. 1 Morphometric evaluation of interstitial fibrosis. a Masson’s trichrome-stained sections of kidney cortices from neonatal rats (SHRs and
WKYs). 0 W: newborn rat; 2 W: 2-week-old rat; 4 W: 4-week-old rat; 6 W: 6-week-old rat; and 8 W: 8-week-old rat. Magnification: 400X. b Masson’s
trichrome revealed a significant expansion of the interstitial space in kidney cortices from 8-week-old SHRs compared to the cortical areas of WKY
kidneys (SHR vs. WKY; *p < 0.05). Results are mean ± SEM; n = 5
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urogenital development but also during fetal and postna-
tal life. Furthermore, using laser microscopy techniques,
WT-1 was sub-located in the nucleus cell, regardless of
cell type and stage of development. Moreover, it has
been concluded that the initial growth of the ureteric
bud is dependent on a signal from the metanephric blas-
tema and WT-1 would be necessary for this [28–30].
Therefore, WT-1 is essential for normal kidney develop-
ment [31].
In contrast, nephrogenic deficiency has been recog-
nized as a powerful risk factor for kidney disease, condi-
tioning a more rapid progression of the disease and the
possible development of hypertension [2]. Our group
has confirmed this in the present study when quantify-
ing/qualifying the glomeruli of SHRs compared to those
of WKYs, from birth to hypertension development. Spe-
cifically, a slight decrease in the number and diameter of
glomeruli was found in 4-week-old rats, while a signifi-
cant decrease was found in 8-week-old rats. Similarly,
we established significant changes in renal function (urea
and creatinine) only in 8-week-old rats. In parallel, we
could establish a close relationship of these parameters
and WT-1 expression, which was clearly lowered espe-
cially in 8-week-old rats. This is consistent with previous
reports from our laboratory where a low expression of
WT-1 in neonatal rats with kidney disease was associ-
ated with glomerular changes and reduced nephrogenic
markers such as Snail, BMP-7 and E-cadherin [32].
However, the most striking finding of the present study
was to establish that, first, there were changes in WT-1
Fig. 2 Identification and quantification of cellular apoptosis. a Localization of apoptotic nuclei by TdT-uridine-nick-end-labeling technique. Apoptotic
nuclei appear as heavy brown-stained nuclei in tubule epithelial cells. In 8-week-old rats, apoptotic nuclei in SHR renal cortices appear as heavy brown-
stained nuclei in collecting ducts and in lesser proportions in proximal tubules, whereas there is a slight increase in apoptotic cells in the epithelium
from collecting ducts and proximal tubules in WKY kidney cortices. Magnification: 400X. b Quantification of apoptotic epithelial cells in cortices. More
TUNEL-positive nuclei were recorded in tubular epithelial cells of renal cortices from SHRs than in those from WKYs (8 week-old rats); *p < 0.05. Each
bar represents mean ± SEM; n = 5
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expression linked to glomerular alterations (in 4-week-
old rats), and then, these were followed by hemodynamic
changes with elevation of blood pressure (in 6-week-old
rats). To support this, genes typically involved in the
process of hypertension development are also WT-1
dependent [5, 33]. Interestingly, inherited mutations in
the WT-1 gene can lead to life-threatening hypertension
[5]. Thus, the renin gene transcription is regulated by
the WT-1 (−KTS) protein and this could explain the
findings in patients with WT-1 mutations that occur
with increased plasma renin and hypertension. There-
fore, and of particular interest to our current discussion,
one important consequence of the altered nephrogenic
process is hypertension development, which further
Fig. 3 Electron microscopy study in neonatal SHRs and WKYs. Effects of hypertension development in mitochondria of renal cortical cortices of
newborn SHR (a) and WKY (b), 4-week-old SHR (c) and WKY (d), and 8-week-old SHR (e) and WKY (f). Note that the mitochondria present dilated
mitochondrial crestae (arrows; c and e) in the tubules of SHRs. Convoluted distal tubules of WKYs (b, d and f) showing normal ultrastructure were
included for comparison. Magnification: 60,000 (a), 58,000 (b), 70,000 (c, d and f), and 65,000 (e)
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amplifies the risk of onset and progression of kidney dis-
ease [33]; this makes it controversial to analyze whether
hypertension is a cause or a consequence of kidney
disease.
To emphasize our findings, WT-1 plays a key role in
the onset of kidney formation, the progression of kidney
formation and the maintenance of normal kidney func-
tion. The WT-1 protein participates in diverse cellular
processes such as proliferation, differentiation and apop-
tosis and, in accordance with these functions, the num-
ber of target genes and/or proteins it affects is still
increasing [34]. Particularly, the cells of the glomerulus,
the proximal tubules and the distal tubules all derive
from the metanephric mesenchyme where WT-1 already
plays an active role [35]. According to this, in addition
to glomerular alteration, we also established a significant
change in the morphometric evaluation of fibrosis and
apoptosis in glomerulus and tubular cells. Contrary to
our results, apoptosis was markedly decreased in the
kidneys of neonatal SHRs compared with their normo-
tensive controls [36]. Nevertheless, it should be noted
that the cited study was conducted in newborn SHRs
within the first week of life, a period when we did not
find significant changes. Previously, we had demon-
strated an increase on renal interstitial fibrosis and
apoptosis in adult SHRs [10]. However, this is the first
study using the essential hypertension model which
established a lesser WT-1 expression level occurring par-
allel to renal morphometric changes during late renal
development and its consolidation as an adult organ.
This is a key finding, considering that nephrogenesis in
rats continues many days after birth. Thus, renal devel-
opment in the newborn rat is comparable to that of the
midtrimester human fetus, while renal maturation in the
Fig. 4 Effects on glomerular number and size during hypertension development. a The relative number of glomeruli per square millimeter of
renal cortex was significantly lower in 8-week-old SHRs than in WKYs (*p < 0.05). No substantial changes in number were observed among WKYs
during the 8 weeks studied. b A significant decrease in glomerular diameter was found in 8-week-old SHRs relative to WKYs (*p < 0.05). As with
the number of glomeruli, no substantial changes in glomerular size were observed among WKYs. Results are mean ± SEM; n =5
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Fig. 5 a Histological sections of neonatal SHR kidney cortices during hypertension development. In newborn SHRs (0 W), WT-1, VDR and Hsp70
immunostaining (expression) was relatively high, and it decreased in the cytoplasm of tubule epithelial cells and in glomeruli, while AT1 staining
was observed in the same epithelial duct segments. After 4 weeks of hypertension evolution, decreased WT-1/VDR/Hsp70 immunostaining levels were
seen in cortex tubule cells, and there was higher AT1 staining in tubule cells (4 W vs. 0 W). Finally, after 8 weeks of hypertension development, a greater
decrease in WT-1/VDR/Hsp70 immunostaining levels were seen in cortex tubule cells, compared to what was seen in newborn SHRs (8 W
vs. 0 W). Also, a very high level of AT1 staining in the tubule cells and glomeruli of the 8-week-old SHR was observed (8 W vs. 0 W).
Magnification: 400X. b Histological sections of neonatal WKY kidney cortices. In newborn WKYs (0 W to 8 W), WT-1, VDR and Hsp70 immunostaining
(expression) was relatively high, while an AT1 low staining was observed in the same epithelial duct segments. Magnification: 400X
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2-week-old rat is analogous to that of the human infant
[37]. Interestingly, Dr. Chevalier demonstrated that renal
growth is impaired and nephron number is reduced in
14- to 19-day-old rats with obstructive nephropathy
[38]. Using the same model, we have reported a signifi-
cantly low expression of WT-1 in neonatal rats linked to
glomerular changes and reduced nephrogenic markers
[32]. Hence, kidney impairment is a significant event in
hypertension development and, thus, alteration of a key
nephrogenic gene expression such as WT-1 appears to
contribute to hypertension development.
On the other hand, recent studies in hypertension
have shown low levels of vitamin D linked to RAAS
exaltation [6, 39, 40]. Moreover, Hsp70 regulates signal-
ing pathway responses to cellular oxidative stress; and,
in that respect, our laboratory has shown that Hsp70
protects against angiotensin II-induced hypertension [9].
We examined the effect of losartan on the expression/
localization of Hsp70 in primary cultures of proximal
tubular cells of SHRs, and demonstrated that the mem-
brane translocation of Hsp70 could exert a protective ef-
fect by reducing the activity and expression of NADPH
oxidase. In line with these studies, we also demonstrated
in adults SHRs that structural and functional changes
were reversed by VDR induction and that the association
with enalapril worked even better. Thus, our recent data
suggest that a low AT1 expression through VDR induc-
tion could be a consequence of Hsp70-mediated cell
protection [10]. These concepts could be critical in un-
derstanding the complex interplay between VDR and
RAAS for hypertension and related inflammatory disor-
ders. Unprecedentedly, and occurring previous to the
increase in blood pressure, we demonstrated low expres-
sions of VDR and Hsp70 linked to a poor WT-1 level in
the renal cortices from 4-week-old SHRs. Contrary to
this, AT1 staining was observed in the same SHR epithe-
lial cells. These values were very significant in 8-week-
old rats. These data are revealing in the light of previous
Fig. 6 a Immunofluorescence confocal microscopy study in SHRs. Immunofluorescence/cytochemical localization of WT-1, VDR, Hsp70 and AT1 in
kidney cortices from SHR rats. Renal cortex tissues were labeled with antibodies against WT-1, VDR, Hsp70 and AT1 followed by anti-rabbit fluorescein
isothiocyanate-conjugated, and anti-mouse Rhodamine Red and Green X-conjugated secondary antibodies. Nuclei were stained with Hoechst 33342
(blue). Images represent five different experiments. In tubule epithelial cells of the newborn SHR (0 W), greater WT-1 (red), VDR (green) and Hsp70 (red)
staining were identified. Similarly, basal expression of AT1 (green) appears in the tubule epithelial cells. Surprisingly, at week 4 of hypertension development,
immunoreactive WT-1, VDR and Hsp70 decreased in the cytosol and the membrane of epithelial tubule cells. In addition, at week 8, these parameters were
very low. Contrarily, at week 4 of hypertension development, immunoreactive AT1 in the cytosol and the membrane of epithelial tubule cells increased,
and at week 8, it was very high. Magnification: 600X. b Immunofluorescence confocal microscopy study in WKYs. Immunofluorescence/cytochemical
localization of WT-1, VDR, Hsp70 and AT1 in kidney cortices from WKY rats. Renal cortex tissues were labeled with antibodies against WT-1, VDR, Hsp70 and
AT1 followed by anti-rabbit fluorescein isothiocyanate-conjugated, and anti-mouse Rhodamine Red and Green X-conjugated secondary antibodies. Nuclei
were stained with Hoechst 33342 (blue). Images represent five different experiments. In tubule epithelial cells of the newborn WKY (0 W to 8 W), high WT-1
(red), VDR (green) and Hsp70 (red) staining were identified. In addition, a low expression of AT1 (green) appears in the tubule epithelial cells. Interesting, at
week 8, immunoreactive WT-1, VDR and Hsp70 not decreased in the cytosol and the membrane of epithelial tubule cells. Also, at week 8, immunoreactive
AT1 not increased in the cytosol and the membrane of epithelial tubule cells. Magnification: 600X
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contributions. WT-1 and Hsp70 are physically associated
in rat kidney cells, in primary Wilms’ tumor samples
and in cultured cells with inducible expression of WT-1.
Hsp70 is recruited to the characteristic sub-nuclear clus-
ters containing WT-1. In addition, WT-1 requires
amino-terminal transactivation domain for binding to
Hsp70, and the expression of that domain itself is suffi-
cient to induce the expression of Hsp70. Replacing the
Hsp70 binding domain is sufficient to restore the func-
tional properties of WT-1. These observations indicate
that Hsp70 is an important cofactor for the function of
WT-1, and suggest an emergent role of Hsp70 during
nephrogenesis [11]. VDR, a ligand-activated transcrip-
tion factor, is also regulated by WT-1. In humans, mul-
tiple assays suggested that, while WT-1 can choose from
three binding sites within the VDR promoter, the VDR
gene activation seems to occur through a single site.
This site differs from a site-sensitive WT-1 previously
identified in the murine VDR promoter [12]. Accord-
ingly, the evidence suggests that there could be a modu-
lation between Hsp70, VDR and WT-1. Moreover, the
decoupling between Hsp70 and VDR associated with a
possible poor expression of WT-1 could be keys to
hypertension development.
In the present study, we have demonstrated that there
was ultrastructural damage at the mitochondrial level in
the renal cortices of neonatal SHRs. In addition, a pres-
ence of high AT1 and NADPH oxidase activity coupled
with low WT-1, VDR and Hsp70 expressions were con-
sistent with the histological and structural changes dem-
onstrated. Importantly, hypertensive-induced renal injury
is characterized by activation of several deleterious path-
ways, including oxidative stress, RAAS, renal remodeling,
poor vitamin D levels and apoptosis, all of which may
compromise mitochondrial integrity and function. Mito-
chondria are the main generators of reactive oxygen spe-
cies (ROS) in cells, yet their pathophysiological role in
hypertension and related inflammatory diseases remains
to be fully clarified [13]. Mitochondrial dysfunction has
been implicated in the etiology of many diseases, like
hypertension, and, among the many factors involved, our
laboratory has characterized in mitochondria the RAAS
exaltation and deficiency of vitamin D receptor [6, 10, 39].
In this paper, we have demonstrated that proximal convo-
luted tubules display normal tubular cells with baseline
projections within normal parameters. They had abundant
mitochondria, mostly with normal ultrastructure, except
for some beginning to show changes, such as wider spaces
than expected between the mitochondrial cristae. More-
over, in 8-week-old SRHs, the architecture of the renal tis-
sue was disorganized, and the cellular structure was also
altered. These cells contained vacuoles, mitochondria with
cristae separated by widened spaces between them –some
of them containing vacuoles and dense bodies surrounded
by membranes. In the last decade, it has been shown that
ROS and inflammation, with special attention to mito-
chondria, play an important role in the development of
hypertension [13, 41]. In this regard, our laboratory pro-
posed a complex interplay between inflammatory pathway
regulation and Hsp70 [42]. One mechanism that has re-
cently been discussed by our work group and other la-
boratories is the possible involvement of Hsp70 and WT-1
on mitochondrial signaling pathway, where the net effect
would favor cell survival by WT-1 stabilizing Bcl2, and
would limit the potential for release of cytochrome C from
mitochondria [15]. Also, Hsp70 interacts with the VDR
and plays a role in controlling VDR concentrations within
cells [43]. Vitamin D has also been demonstrated to be a
nontoxic inducer of Hsp70 in the rat kidney [44]. NADPH
oxidase activity was reverted in mitochondrial fractions
from vitamin D inducer-treated animals [19]. Further-
more, VDR-modulated Hsp70/AT1 expression may pro-
tect the structure and function of SHR kidneys [10]. In
addition, transcriptional activation of the VDR by WT-1
can mediate programmed death of renal embryonic cells
in response to 1,25-(OH)(2)D(3) [45]. Thus, previous evi-
dence and our present findings support a key role of the
vitamin D endocrine system in renal cell growth and dif-
ferentiation during hypertension development. Moreover
and in accordance with our current findings, maternal
vitamin D deficiency accompanies changes in the expres-
sion of important renal factors that can slow maturation
of glomeruli, extending the period of nephrogenesis [46].
Collectively, we propose an original hypothesis holding
mitochondrial dysfunction as a precursor of hypertension.
Fig. 7 NADPH activity in mitochondrial fractions from renal cortices
during hypertension development. NADPH oxidase activity was
observed in SHRs and WKYs: newborn rats (0 W), 2-week-old rats
(2 W), 4-week-old rats (4 W), 6-week-old rats (6 W) and 8-week-old rats
(8 W). Specifically, NADPH oxidase activity in mitochondrial fractions from
kidney cortices increased at week 4 and 6 of hypertension evolution (*p
< 0.05, both ages), while it was considerably higher only in the 8-week-
old SHR, compared to the normotensive control (WKY) (**p< 0.01). Each
bar represents mean ± SEM; n= 5
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The potential for interaction between Hsp70 and VDR in
mitochondria could be a cause or consequence of WT-1
modulation (Fig. 8, proposed hypothesis graph).
Conclusions
The originality of the proposal presented in this paper is
the idea that, in the natural history of hypertension, ultra-
structural mitochondrial damage occurs first, before
hemodynamic clinical manifestations appear. The altered
mitochondrial energy metabolism linked to master nephro-
genic factors, such as WT-1, could play a central role in the
essential hypertension model, and should be further investi-
gated. Unprecedentedly, we show opposing relationships
between blood pressure levels in relation to the WT-1
nephrogenic factor and related genes. To our knowledge,
this is the first study that finds that hypertension may be a
result of possible changes in renal development by decoup-
ling organogenic key factors. Finally, although the relation-
ship between hypertension and kidney disease remains
unclear and a matter of considerable interest for research,
our current results provide new evidence suggesting that
essential hypertension would result as a consequence of
kidney disease with nephrogenic disturbances. Further
studies should be designed to validate our findings and
allow the implementation of novel therapeutic tools for
hypertension.
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